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Infectious diseases are a major health concern in South Africa and many other 
developing countries. The local development of medical devices for infectious 
diseases in such settings, utilizing the local knowledge base, has the potential to 
improve the accuracy of and access to diagnoses and to lead to the devices being 
more context-appropriate and affordable. The aim of this project was to examine the 
landscape of diagnostic medical device development targeting infectious diseases 
prevalent in South Africa for the period 2000-2016, particularly with regard to 
collaboration between institutions in different sectors and the contributions of different 
collaborators. Such knowledge would be beneficial to future technological and policy 
developments aimed at improving access to diagnostic services and treatment in the 
South African context. 
 
Collaboration across four sectors was considered: university, hospital, industry and 
science councils and facilities. A bibliometric analysis was performed, and publications 
documenting medical device development for diagnosis of infectious diseases were 
extracted. Co-authorship of the journal and conference articles was used as a proxy 
for collaboration across organisations. Affiliation data extracted from the publications 
were used to generate a collaboration network. Netdraw, a network visualisation tool, 
was used to visualize the network, and network metrics such as degree centrality, 
betweenness centrality and closeness centrality, as well as group density measures, 
were produced using UCINET software. The collaboration network and the network 
metrics were used to determine which organisations have collaborated and which 
collaborators have played the most active and influential roles in diagnostic device 
development. The university sector was found to make the largest contribution to the 
development of diagnostic medical devices in South Africa, and also played a key role 
in transmitting information throughout the network due to its high frequency of 
connections to other organisations. The most prevalent type of inter-sectoral 
collaboration was between universities and science councils and facilities, while 
universities were found to collaborate most amongst themselves with regard to intra-
sectoral collaboration. Foreign organisations played a prominent role in diagnostic 
device development between 2012 and 2016. Tuberculosis was the most prevalent 
infectious disease in diagnostic device development research, and computer-aided 




Infectious diseases continue to be a major health concern in many low income and 
developing countries with poorly resourced health systems (Mcnerney, 2015). Leading 
communicable diseases such as HIV/AIDS, tuberculosis, malaria, diarrheal diseases 
and lower respiratory tract infections collectively account for approximately a third of 
all deaths in these countries every year (Santoro et al., 2015). In the South African 
context, HIV/AIDS and tuberculosis were among the top ten leading causes of death 
in the years 2005 and 2016, as shown in Table 1-1. 
 
Table 1-1: Top 10 causes of death in 2005 and 2016 (table adapted from Institute for Health 













A number of strategies have been implemented in an attempt to reduce this burden of 
disease, including vaccination programs, health education, the use of mosquito 
repellant bed nets in malaria-endemic areas, improved provision of clean water and 
sanitation and mass administration of drugs in remote communities; even so, 
appropriate clinical management of patients continues to present a significant 
challenge in global health (Peeling and Mabey, 2010). 
 
The 20-year End-TB Strategy, adopted by the World Health Assembly in 2014, is one 
example of a global strategy aimed at eliminating one of the deadliest infectious 
diseases in the world, tuberculosis (World Health Organization, 2015). Similarly, the 
Sustainable Development Goals, which were approved by the General Assembly of 
the United Nations in 2015, have committed to ending epidemics of HIV/AIDS, 
tuberculosis, malaria and neglected tropical diseases, as well as to combating 
2005 2016 
HIV/AIDS HIV/AIDS 
Lower Respiratory Tract Infection Ischemic Heart Disease 
Tuberculosis Lower Respiratory Tract Infection 
Ischemic Heart Disease Diabetes 
Cerebrovascular Disease Cerebrovascular Disease 
Diabetes Tuberculosis 
Road Injuries Road Injuries 
Interpersonal Violence Interpersonal Violence 
Diarrheal Diseases Chronic Obstructive Pulmonary Disease 
Chronic Obstructive Pulmonary Disease Diarrheal Diseases 
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hepatitis, water-borne diseases and other communicable diseases by 2030 (Osborn 
et al., 2015). Targeted disease elimination and control programmes, including wider 
treatment and vaccination coverage and increased funding to support medical 
research have contributed to the decline in the incidence of communicable diseases 
between 2000 and 2015, however further expansion of these interventions, particularly 
in regions with a high disease burden, are required to reach the 2030 goals (UN, 
2017). 
 
The burden of infectious diseases falls mainly on vulnerable parts of the population, 
wherein financial, structural and geographical access to healthcare is limited. Lack of 
access to good quality diagnostic tests for infectious diseases results in the 
mistreatment of illnesses (Peeling and Mabey, 2010; Mcnerney, 2015). Clinical 
laboratories and diagnostic services in developing countries are typically sparsely 
distributed or under-resourced, and most diagnostic tests tend to be too expensive for 
healthcare providers and patients (Berkelman et al., 2006; Mcnerney, 2015). In such 
cases, diseases are typically diagnosed based on clinical symptoms and local disease 
prevalence; while this approach is able to identify most patients requiring treatment, it 
also results in the unnecessary treatment of misdiagnosed patients at the expense of 
limited funds and resources (Yager et al., 2008).  
 
1.1 Diagnostic Devices 
 
Laboratory testing has become increasingly automated, resulting in improved 
reliability and efficiency. However, the devices themselves remain centralized and 
require highly trained staff, specialised facilities (Drain et al., 2014) and developed-
world resources not readily available in developing countries. Consequently, such 
tests are typically inaccessible to patients and clinicians in developing regions (Drain 
et al. 2014; Peeling & Mabey 2010). Therefore, while diagnostic tools are important 
for patient management and disease control, the effectiveness of these tools is 
dependent on how well the environment in which they were designed to be used, 
matches the environment in which they are implemented. 
 
When it comes to health care services and research, there is a difference in priorities 
between high- and low-resource countries. While patients in high-resource countries 
 6 
focus on advanced diagnostic technologies, patients in low-resource countries would 
benefit from simple and affordable diagnostic tools which would improve accessibility 
to appropriate medical care (WHO, 2010). The mismatch in the supply and demand of 
diagnostic devices negatively impacts low-resource settings and thus creates a gap in 
the market for the development thereof (WHO, 2010).  
 
Tests designed for use in developed countries are often not readily available or 
transferable to resource-limited countries. For example, rapid diagnostic tests for HIV 
(Ghani et al., 2015), the GeneXpert MTB/RIF test used for the detection of 
Mycobacterium tuberculosis DNA (Mcnerney and Zumla, 2015) and rapid diagnostic 
tests for malaria (Rao et al., 2013) have proven to be inconclusive and unreliable when 
used in low-income settings. Barriers include general lack of infrastructure, unreliable 
water and electricity resources, lack of staff training and incorrect specimen collection 
in developing countries (Peeling and Mabey, 2010; Begg, Young and Stone, 2011; Pai 
and Pai, 2012; Mcnerney, 2015). There is often a lack of knowledge in the clinical 
setting as to how to operate the devices and ensure consistent efficacy (Peeling and 
Mabey, 2010). Given that the sensitivity of diagnostic instruments and reagents may 
be reduced in resource-poor settings, there is a need for the development of simple, 
robust and cost-effective tests that can withstand extreme conditions and the lack of 
skilled technicians (Mehta and Cook, 2010). However, not many medical devices are 
manufactured in developing nations, instead the majority of devices used in healthcare 
in such countries have been imported (World Health Organization, 2010). 
 
Decentralized diagnostic analysis carried out at the site of care is known as point-of-
care testing (POCT) (Luppa et al., 2011). Examples of POC tests include blood 
glucose tests, pregnancy tests and urine tests, all of which provide some information 
about the patient’s physiology and prevent the delay of treatment (Choi, 2016). POCT 
can increase the speed with which clinicians receive results and reduce waiting times 
from days to hours, as the need for sample transport and laboratory processing is 
eliminated (Kost, 2002). The key objective of POCT is to generate a rapid result so 
that the appropriate treatment may be implemented, leading to a better clinical and 
economic outcome (Price, 2001). Furthermore, unlike laboratory testing methods, 
which require specific facilities and complex procedures, POCT offers a more 
distributable diagnostic analysis which includes benefits such as automation and 
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portability (Choi, 2016). Simple and easy-to-use POCT devices would be beneficial in 
resource-limited areas. 
 
Through improved access to fast and accurate diagnostic testing, both using POCT 
and other diagnostic devices, disease progression in developing countries would be 
mitigated, which could ultimately reduce disease transmission rates and mortality 
rates in disadvantaged communities. The local development of medical devices for 
infectious diseases in resource-limited settings, utilizing the local knowledge base, has 
the potential to improve the accuracy of and access to diagnoses and to lead to the 
devices being more context-appropriate and affordable. The End-TB Strategy 
identifies the lack of effective diagnostic tools as a barrier to ending the global TB 
epidemic, and considers a point-of-care test for the rapid diagnosis of TB disease and 
latent infection as one of the crucial elements for achieving complete TB elimination 
by the year 2035 (Uplekar et al., 2015). 
 
1.2 Collaboration for Medical Device Development 
 
Medical device development is a multi-disciplinary endeavour that requires 
contributions from different sectors. The sectors known to be involved (Hicks and Katz, 
1996; Lander, 2013; Chimhundu et al., 2015), include the university sector, which 
contributes scientific research, the hospital sector which provides clinical expertise, 
and the industry sector which provides insight into product development and 
distribution. Additional sectors, such as government departments and non-
governmental organizations sometimes participate in scientific research as 
collaborators (Lander, 2013). In South Africa, science councils are focused on 
conducting social, technological and scientific research in accordance with their 
commission by the South African government under the Scientific Research Council 
Act 46 of 1988 (South African Government, 1990) and play a role in collaboration for 
diagnostic device development (Chimhundu et al., 2015; de Jager et al., 2017) 
 
Through collaboration, knowledge can be transferred between the different sectors 
(Lander, 2013; Chimhundu et al., 2015). Such collaborative interactions can be 
represented by a collaboration network, defined by Tijssen (1998) as a growing mutual 
dependency system based on the ability to exchange resources. By mapping 
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collaboration networks, social network analysis tools can be used to develop an 
understanding of the collaboration activities. Examples exist in the literature where 
collaboration networks were used to explore the extent of collaboration between 
sectors, the strength of collaborations and the patterns of collaboration for health-
related innovation (Lander, 2013, 2014; Chimhundu et al., 2015; Fonseca et al., 2016). 
 
Some work has been done to understand the development of medical devices, and 
the associated collaborative activities within South Africa. For example, Chimhundu et 
al. (2015), analysed sectoral collaboration for cardiovascular medical device 
development in South Africa over a 15-year period with the purpose of establishing 
which sectors and organisations play a role in the development thereof, while de Jager 
et al. (2017) characterized the broad medical device landscape with regard to 
collaboration in South Africa over a 14-year period. Salie et al. (2017) showed that 
devices related to the immune system are one of four device types with the highest 
number of local organisations involved in their development. Although devices related 
to the immune system may address the diagnosis of infectious diseases (Salie et al., 
2017) little is known about diagnostic devices as a category and the extent of activity 
for their development in South Africa. 
 
1.3 Problem Statement 
 
Diagnostic devices with local input are required to address the local burden of disease, 
however little is known about diagnostic device development for infectious diseases 
in South Africa. Mapping the South African landscape would provide a basis from 
which to promote local diagnostic device development. 
 
Generating and analysing the collaboration network for diagnostic device development 
in South Africa is a first step in understanding the landscape. The network will help 
ascertain who the key role players are, to which sectors they belong, and what 
collaborations they have formed. Such knowledge may form a basis for analysis of 
success factors for productive collaboration, and may be beneficial to future 
technological and policy developments aimed at improving access to diagnostic 
services and treatment in the South African context. 
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1.4 Aims and Objectives 
 
The aim of this project was to examine the landscape of diagnostic medical device 
development targeting the diagnosis of infectious diseases prevalent in South Africa, 
particularly with regard to collaboration between organisations in different sectors and 
the contributions of different collaborators. 
 
In order to achieve the aim, the following objectives were pursued: 
o Construct a collaboration network for diagnostic device development in South 
Africa thereby identifying the organisations which are collaborating. 
o Analyse the collaboration network using social network analysis metrics to 
determine which collaborators play the most active and influential roles in 
diagnostic device development. 
 
1.5 Chapter Overview 
 
Chapter 2 provides insight into the literature that supports the different areas of the 
project. The methodology in Chapter 3 describes the steps that were taken to collect 
the bibliometric data on diagnostic device development for infectious diseases and 
outlines the collaborative network analysis approach. Chapter 4 provides a description 
and interpretation of the network analysis findings and compares them to the findings 
of other related publications. Chapter 5 summarises the results and makes 
recommendations for future work.  
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2. Literature Review 
 
Africa has a high burden of infectious disease, and yet a low capacity to manage it 
(Karimuribo et al., 2011). Although some advances have been made towards the 
management and diagnosis of infectious diseases, they continue to pose a 
significant burden on global economies and public health (Jones et al., 2008). This 
burden is primarily driven by weak and poorly resourced health care systems, which 
prevent adequate treatment and reduce the chance of limiting further transmission of 
the diseases. The development of novel devices has the potential to overcome these 
challenges (Mcnerney, 2015). This purpose of this chapter is to provide an overview 
of the literature on the analysis of collaboration networks involved in medical device 
development, and in doing so to identify the gaps that exist in the literature which will 
be addressed by the study.  
 
2.1 Collaborative Research  
 
Collaboration is fundamental to scientific research (Abramo et al., 2011). Collaborative 
research and development has the ability to facilitate the transfer of knowledge 
between different sectors (Lander, 2013) and therefore has the potential to bridge the 
gaps in information and resources that exist in developing public health structures. 
Collaboration is beneficial in that it allows for the interaction of various networks, 
organizations and disciplines, either within or affiliated with the public health sector, 
which drives innovation and design (Sala et al., 2011). 
 
Three sectors are known to be active within healthcare innovation (Hicks and Katz, 
1996) namely universities, healthcare services, such as hospitals and clinics which 
are mainly focused on patient care, and industry. The university sector is primarily 
focused on public scientific research, and shows some development activity (Owen-
smith, Arbor and Powell, 2002; Lander, 2013). The healthcare sector is important 
when it comes to determining medical device needs and ensuring that novel 
technologies and applications are appropriate and safe to be used within a clinical 
setting (Chimhundu et al., 2015). The industry sector is the driving force behind the 
manufacturing and distribution of biomedical devices (Ankrah et al., 2013). Another 
set of organisations that has been shown to be involved in medical device 
development in South Africa are science councils and science research facilities 
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(Chimhundu et al., 2015). Science councils are large-scale private or public 
organisations that typically engage in advanced projects that are perceived to be too 
risky for other sectors (Scholes et al., 2008).  
 
The sectors, and their constituent organisations, that engage in healthcare innovation 
can be represented in collaborative networks as a tool towards further understanding 
how they engage in healthcare innovation. A variety of definitions for collaborative 
research networks have been proposed over the years, however Sala et al. (2011) 
cite the definition proposed by Tijssen (1998) as the most comprehensive and 
applicable to different types of networks. This definition states that a collaborative 
network is “an evolving mutual dependency system based on resource relationships 
in which their systemic character is the outcome of interactions, processes, 
procedures and institutionalisation.” Research and development networks have 
increasingly been established and networking activities studied by scholars and policy 
makers (Georghiou and Roessner, 2000) due to the growing interest in a 
multidisciplinary approach to technological and research advancements, and 
recognition of the need for various different skills to develop new ideas and products 
(Sala et al., 2011). 
 
Scientific collaboration can be measured by co-authorship of written publications 
(Newman, 2001) within a given subject area. Although it is limited by the fact that it 
does not reflect all types of collaboration (Laudel, 2002) co-authorship is widely 
considered as a reliable proxy for scientific collaboration. Co-authorship analysis is an 
important tool that can be used to investigate collaborations between individuals, 
organisations and countries, and help interpret collaboration patterns (Newman, 2001; 
Meyer and Bhattacharya, 2004). Chimhundu et al. (2015) and de Jager et al. (2017) 
used co-authorship as an active indicator of collaboration in their respective studies 
on medical device development in South Africa. Collaborations can be visualised 
using network graphics, which allows for further analysis of the collaboration between 






2.2 Bibliometric Strategies 
 
The extraction and quantitative analysis of publications, often from available literature 
databases is known as a bibliometric analysis. As a first step, a search profile 
consisting of specific search terms that will yield the desired data set is created. The 
search terms are typically made up of a geographical aspect, an indicator of 
performance, such as development over a given time period, particular subject 
domains, types of authorship and publication types (e.g. journal article, review paper 
or conference proceeding) (Ellegaard and Wallin, 2015). For example Lander (2013), 
who conducted a bibliometric study of Vancouver, Canada’s infection and immunity 
research and development network, searched for Canadian journal articles during a 
specific time period. This dataset was filtered and only articles discussing research 
relevant to infection and immunity research and development were retained. A similar 
process was followed by de Jager et al. (2017) who conducted a broad overview of 
medical device development in South Africa, and Chimhundu et al. (2015), who 
structured their search profile to yield a search output related to cardiovascular 
medical device development in South Africa. 
 
2.3 Social Network Analysis 
 
Newman (2001) describes a social network as a group of people that has a connection 
to some or all of the other individuals in the group.  Social network analysis (SNA) is 
an approach that can be used to analyse the interactions within such groups 
(Hanneman and Riddle, 2005). Metrics such as density and centrality can be used to 
describe relationships between actors within the network (Schoen et al., 2014). These 
measures provide a means to assess research collaborations (Bian et al., 2014). SNA 
can provide a first step towards identifying infrastructural and geographical barriers in 
resource-limited settings (Perkins, Subramanian and Christakis, 2015), thereby 
creating a basis for overcoming them.  
 
2.3.1 SNA of medical device collaboration networks 
 
A number of studies have been conducted to examine cross-sectoral collaboration 
networks involved in the development of medical devices. 
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Lander (2013) conducted a study to assess collaborative research and development 
within the infection and immunity network in Vancouver, Canada with the purpose of 
examining the relative importance of different sectors in the network. The sectors 
considered included university, hospital, government, firms and NGOs. By examining 
network structure using various social network analysis tools, it was found that most 
sectors preferred to collaborate within as opposed to across sectors, and that 
university-hospital collaborations play a key role in the particular network studied. This 
finding was in agreement with a bibliometric study conducted by Hick and Katz (1996) 
wherein it was found that universities and hospitals collaborated more than expected 
in the United Kingdom science base. 
 
Chimhundu et al. (2015) conducted a study to analyse the development of 
cardiovascular medical devices (CMD) in South Africa over a period of 15 years using 
co-publication of journal articles as an indicator of collaboration. The purpose of this 
study was to: identify the dominant organisations and sectors within the CMD 
development network, and the different ways they collaborate; measure the scope of 
collaboration within the network; and analyse the collaboration trends over time. 
Collaboration across four sectors was taken into consideration, namely healthcare 
services, industry, universities and science councils. This study found that in the South 
African network, the most prominent inter-sectoral collaboration was between the 
healthcare and university sectors. The science councils, healthcare and industry 
sectors were found to collaborate most with the university sector, thus indicating that 
the university sector is the foundation of the South African CMD co-publication network 
(Chimhundu et al., 2015). In a follow-up study, Chimhundu et al. (2016) investigated 
the focus of cardiovascular medical device research in South Africa using the same 
data set, and found that the research focused on diagnostic, monitoring and prosthetic 
cardiovascular medical devices. 
 
De Jager et al. (2017) examined the broad South African medical device landscape 
between 2000 and 2013 through a bibliometric analysis of relevant scientific papers 
using co-authorship as an indicator of collaboration. A collaboration network was 
generated and used to: identify the most active and dominant organisations and the 
sectors to which they belong; determine the extent of collaboration within and between 
sectors; investigate the influence of foreign collaborators; and explore various 
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collaboration types, focusing specifically on translational collaborations. The university 
sector was found to be the most dominant sectors, with the three highest ranking 
organisations being the University of Cape Town, Groote Schuur Hospital and the 
University of Stellenbosch. With regard to intra-sectoral collaboration, organisations 
within the university sector (A) collaborated most amongst themselves, followed by 
the hospitals (H) and science councils (S). The industry sector (I) was also considered 
in the analysis. Local and foreign organisations were equally present in the network, 
however local organisations were found to collaborate more with each other than with 
foreign organisations. Translational collaborations, which include three possible 
combinations of the four sectors (i.e. AHI, HIS and AHIS), were examined as they are 
considered key to implementation and commercialisation of medical devices. Few 
translational collaborations were present in the South African medical device 
development network, therefore leaving room for more collaborations of this nature to 
be established. 
 
Salie et al. (2017) examined the focus areas of published research on medical device 
development in South Africa between 2001 and 2013. The results showed that device 
development was most frequently related to the cardiovascular, nervous, skeletal and 
muscular systems. Since devices related to the skeletal and muscular systems were 
the most prominent, Salie et al. (2017) further explored orthopaedic devices through 
actor and keyword collaboration networks. Co-authorship was used as an indicator of 
collaboration for the actors, and keywords were linked if they appeared on the same 
publication. While the relations between actors was sparse in the network of 
organisations involved in orthopaedic device development, a keyword network 
analysis revealed substantial potential for organisations to connect based on shared 
common areas of interest (as indicated by the keywords they use in their publications). 
 
2.3.2 SNA of patent data 
 
In addition to academic articles, patents can also be used as indicators of 
collaboration. According to the World Intellectual Property Organization, a patent is 
defined as “a document, issued, upon application, by a government office (or a 
regional office acting for several countries), which describes an invention and creates 
a legal situation in which the patented invention can normally only be exploited 
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(manufactured, used, sold, imported) with the authorization of the owner of the patent” 
(WIPO, 2008). In the same way that publication author information is used to construct 
a collaboration network, information regarding an inventor can be retrieved from a 
patent and used to construct a patent network (Ma and Lee, 2008). Although patent 
data is considered more relevant for industry researchers, comparing this with 
publication data is a useful way to map the interaction between authors and inventors 
(Beaudry and Schiffauerova, 2011) and avoid losing relevant information pertaining to 
technological developments. Giglio et al. (2017) presented a social network analysis 
of patent activity related to cardiovascular medical device development in South 
Africa. The results were compared to those of an analysis of scientific publications. It 
was found that the university and healthcare sector, specifically the University of Cape 
Town, Groote Schuur Hospital and the University of Stellenbosch, were the biggest 
contributors towards cardiovascular medical device activity in both networks. The 
industry sector was more active in patenting than in scientific publication, however the 
local industry was less active in the patent collaboration network. It was also found 
that foreign organisations made a minimal contribution in both networks. Giglio et al. 
(2017) concluded that there is room for more collaboration across the university, 
hospital and industry sectors, which could promote the development of cardiovascular 
medical devices.  
 
2.4 Network Development over Time 
 
Networks develop over time as some actors either leave their professions they 
represent or form different scientific collaborations (Newman, 2001). In addition, short 
analysis periods (e.g. one year) may not reflect longer-term trends in collaboration 
patterns. As a result, researchers have used multi-year time windows to analyse 
collaboration networks. For example, Barabasi et al. (2002) constructed collaboration 
networks over an 8-year period for the purpose of studying the dynamics and evolution 
of a network, while Lander (2013) used a time period of 5 years to capture trends in a 
biomedical research and development network. According to Baum et al. (2003), 
networks that are constructed using a five-year window period are reliable and 
accurate in terms of the strength of the ties in the network. This idea has been 
supported by other researchers such as Eslami et al. (2013), as well as by Newman 
(2001), who stated that the five-year window period is ideal for capturing changes in 
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collaboration patterns. Chimhundu et al. (2015) analysed changes in collaboration 
activity for the cardiovascular medical device networks of South Africa using a 5-year 
moving time window, to examine the activity of different organisations over time and 
identify gaps and potential for future collaboration. The study found a general increase 
in cardiovascular medical device development over a 15-year period, with the 
university and hospital sectors having the highest overall increase in collaboration over 
this period, and suggested that science councils and industry still had potential for 
greater participation by partnering with the dominant sectors.  
 
2.5 Diagnostic Device Development: Gaps in the Literature 
 
The Chimhundu et al. (2015) study was the first published attempt to characterise the 
medical device development landscape in South Africa using social network analysis. 
Studies by de Jager et al. (2017) and Salie et al. (2017) have characterised medical 
device development activity in South Africa broadly and for orthopaedic devices, 
respectively. Giglio (2017) examined patenting networks for cardiovascular devices 
 
The aforementioned studies have indicated the growth in the development of medical 
devices broadly, of cardiovascular devices and of orthopaedic devices in South Africa. 
These studies have shown that there is room for increased collaboration and device 
development in the local context. Some of the research gaps that are mentioned 
across these studies include the need to investigate the motivating factors for 
collaboration (Chimhundu et al., 2015) the need for increased translational 
collaboration within South Africa (de Jager et al., 2017) and the need for knowledge 
transfer between researchers and innovators (Giglio, 2017). Investigating device 
development in South Africa in the context of infectious disease may reveal similar 
gaps and areas that require further research, and provide new insights into the future 





The methodology presented in this chapter, which was used to identify and analyse 
data relevant to diagnostic devices, was based on the approach employed by 
Chimhundu et al. (2015) for cardiovascular medical devices. 
 
3.1 Diagnostic Medical Device Definition  
 
With the rapid growth in the medical device global market came the need harmonize 
national regulations in order to prevent barriers, facilitate trade and improve access to 
novel technologies (World Health Organization, 2003); this led to the formation of the 
Global Harmonization Task Force (GHTF), an organisation consisting of government 
and industry representatives from different parts of the world, which proposed a single 
definition that would encompass all the diverse aspects of medical devices. The widely 
accepted definition has been used by authors in the medical device research field, 
such as de Jager et al. (2017) and Chimhundu et al. (2015). In the former case the 
definition was used as is, while in the latter case the definition was revised to better 
suit the topic of interest, namely cardiovascular medical devices.  
 
The purpose of the present study was to explore the landscape of diagnostic medical 
device development aimed at infectious diseases prevalent in South Africa. As such, 
a definition for diagnostic devices in particular was required. The word ‘diagnostic’ was  
therefore added to the original GHTF (World Health Organization, 2010) medical 
device definition for this study. Only the parts of the definition deemed relevant to 
disease diagnostics were retained, while amendments made to the definition are 
shown in square brackets: 
A [diagnostic] medical device is any instrument, apparatus, implement, 
machine, appliance, implant, in vitro reagent or calibrator, software, material or 
other similar or related article that does not achieve its primary intended action 
in or on the human body solely by pharmacological, immunological or metabolic 
means and that is intended for human beings for:  
• the diagnosis of disease; 
• providing information for medical or diagnostic purposes by means of in 
vitro examination of specimens derived from the human body 
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3.2 Data Collection 
 
Journal and conference publications documenting medical device development for 
infectious diseases were used to analyse research and development (R&D) activity. 
Co-authorship was used as a proxy for collaboration. The publications were obtained 
from public journal databases for the period between January 2000 and December 
2016.  
 
Web of Science, Scopus and PubMed were used to access the literature on infectious 
disease related diagnostic device research using the search phrases shown in Table 
3-1. The type of diagnostic device and method of diagnosis included in the search 
phrase were informed by the GHTF device definition. In addition, the search term 
‘point-of-care’ was included, as this type of device is relevant in developing settings 
such as South Africa The Boolean operators – AND, OR and NOT – were used in the 
search phrase. The use of ‘AND’ limits the search to terms that occur together in one 
document, while the use of ‘OR’ broadens the search to every possible combination 
of the words or terms separated by it. The third Boolean operator, ‘NOT’, excludes the 
words in the subsequent search term so that they do not appear in the results 
(University of Alaska Fairbanks: Elmer E. Rasmuson Library, 2016). Another important 
component of the search phrase is the country of affiliation – South Africa – which 
ensures that all search results are affiliated with at least one South African co-author 













Table 3-1: Search phrases used to obtain scientific articles, with a South African affiliation, 
concerning medical devices that address infectious diseases 
Database Search Phrase 
PubMed 
(((south africa[Affiliation]) AND ("2000/01/01"[Date - Publication] : 
"2016/12/31"[Date - Publication]) AND (HIV OR AIDS OR TB OR 
tuberculosis OR "infectious disease*" OR "parasitic disease*" OR 
"communicable disease*")) AND (point-of-care OR microfluid* OR micro-fluid 
OR paper-based OR "paper based" OR microsys* OR sensor OR detect* 
OR analys* OR microstruct* OR microscop* OR "medical device" OR device 
OR tool OR instrument OR apparatus OR implement OR machine OR 
appliance OR calibrat* OR software OR material) NOT (pharmacolog* OR 
metabolic OR metabolism OR metabolite)) 
Scopus 
AFFILCOUNTRY ( "South Africa" ) AND TITLE-ABS-KEY ( HIV OR AIDS 
OR TB OR tuberculosis OR "infectious disease*" OR "parasitic disease*" OR 
"communicable disease*" ) AND TITLE-ABS-KEY ( point-of-care OR 
microfluid* OR micro-fluid OR paper-based OR "paper based" OR microsys* 
OR sensor OR detect* OR analys* OR microstruct* OR microscop* OR 
"medical device" OR device OR tool OR instrument OR apparatus OR 
implement OR machine OR appliance OR calibrat* OR software OR material 
) AND NOT ( pharmacolog* OR metaboli* ) AND PUBYEAR > 1999 AND 
PUBYEAR < 2017 
Web of Science 
CU = (South Africa) AND PY = (2000-2016) AND (TS = (((HIV OR AIDS OR 
TB OR tuberculosis OR “infectious disease*” OR “parasitic disease*” OR 
“communicable disease*”) AND (point-of-care OR microfluid* OR micro-fluid 
OR paper-based OR “paper based” OR microsys* OR sensor OR detect* 
OR analys* OR microstruct* OR microscop* OR “medical device” OR device 
OR tool OR instrument OR apparatus OR implement OR machine OR 
appliance OR calibrat* OR software OR material)) NOT (pharmacolog* OR 
metaboli*))) 
 
The adequacy of the keywords used in the search was tested in order to ensure that 
all the relevant publications were captured in the dataset. PubMed was used for this 
exercise as it specifically covers health-related research. Keywords associated with 
the publications extracted from PubMed were scanned to determine whether new 
keywords not used in the searches were present. Any new keywords identified in the 
PubMed search results were applied to the existing search phrase, thus a new data 
set was extracted from PubMed. The new keywords included: reagent, screen, 
develop, design, manufacture and innovate. The additional results obtained in this 
manner were evaluated according to the inclusion and exclusion criteria listed below. 
Since no relevant new publications were identified, it was determined that the existing 
search phrase (shown in Table 3-1) was adequate and no additional keywords would 




3.2.1 Inclusion and exclusion criteria 
 
Duplicate papers found across the three database outputs were discarded. The 
remaining search results were manually evaluated by scrutinizing the title, abstract 
and where necessary the body of the articles to ensure that the content related to the 
development of medical devices for infectious diseases in South Africa. Publications 
that did not relate to medical device development were excluded. In this study, the 
development of a device referred to the testing of a new device, or the testing of a new 
implementation of an existing device, such as a software tool or data processing 
method.  
 
Below is a complete list of the inclusion and exclusion criteria applied to the search 
outputs: 
 
1. Publications were required to explicitly focus on diagnostic device 
2. At least one co-author from each publication was required to be affiliated with 
a South African organisation.  
3. Conference and journal articles were included, while review articles were 
excluded as the latter does not present new developments but rather discusses 
existing technologies. 
4. Publications discussing the development of new devices were included. The 
testing of a new device was considered as a contribution towards the 
development of the device, and therefore included. 
5. Testing of commercially established devices (for example MRI machines, FDG-
PET scans and microscopes) was not included unless a novel application of 
the device was being presented (for instance new software, or a new data 
processing method or component was incorporated into the device).  
6. Studies that used animal models to test the efficacy of diagnostic devices were 
considered, provided the research paper made a link to the human healthcare 
implementation of the study outcome. However, if the paper was specifically 
aimed at diagnostic tests in the context of animal healthcare, it was excluded.  
7. Studies were excluded if their primary mechanism of action of the intervention 
in or on the body was achieved only through pharmacological, metabolic and 
immunological means.  
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3.3 Sectors involved in Diagnostic Device Development 
 
The same four sectors identified by Chimhundu et al. (2015), were expected to be 
found in the dataset of this project. The author affiliations, extracted from the 
publications retained for analysis, were assigned to each sector. The separation into 
different sectors is important as it provides a representation of how different sectors 
affect the functioning of a network (Lander, 2013). The four sectors contribute as 
follows: 
• Industry (I): Companies, firms, organisations and individuals that are involved 
in the development of medical devices that will be made commercially 
available. 
• Healthcare Services (H): Clinics, hospitals, medical centres and private 
practitioners that are solely focused on patient healthcare. 
• Universities (U): Tertiary-level educational institutions that contribute to 
academic research for the development of medical devices. 
• Science councils and facilities (S): Science councils and research centres that 
contribute to scientific research. 
 
Other non-commercial sectors, such as government departments and non-
governmental organizations (NGOs) were considered under the science councils and 
facilities sector. The role of science councils in the South African context is to promote 
science, engineering, technology and innovation, and to drive policy development 
(National Science and Technology Forum, 2014).  
 
3.4 Analysis of the Diagnostic Device Landscape 
 
Netdraw (Borgatti, 2002), a network visualization tool, was used to visualize the 
network of organisations to which publication authors were affiliated, and network 
metrics were calculated using UCINET(Borgatti et al., 2002). 
 
The information in a network is defined by actors (nodes) and relations (edges) 
(Hanneman and Riddle, 2005) In this study, the nodes represent organisations that 
have contributed towards diagnostic device development. Each node was classified 
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as either a South African entity, or a foreign entity. All foreign entities included in the 
network had collaborated with a South African organisation on a publication. Nodes 
were linked by edges only if co-authors affiliated with the nodes (organisations) had 
produced a publication together. The edges were weighted in proportion to the number 
of times two nodes have collaborated, as was done by Chimhundu et al. (2015). 
Furthermore, given that collaboration is a mutual relationship, the edges were 
undirected (Chimhundu et al., 2015). 
 
Group density, average path length and three measures of centrality were used to 
quantify the structure of the network, and to identify the dominant actors:  
• Group density quantifies the extent of interconnectedness between groups. It 
can therefore be used as a measure of the collaboration within and between 
sectors. Group density is calculated by dividing the number of edges actually 
present in the network by the total number of possible edges that could be 
present in the network provided all nodes were interconnected (Hanneman and 
Riddle, 2005) 
• The power or influence of a given node in a network is dependent on how 
favorable the position of the node is with respect to other actors in the network 
(Hanneman and Riddle, 2005). Measures of centrality (degree, closeness and 
betweenness) can be used to identify influential nodes in a collaboration 
network (Chen et al., 2012) and describe the location of a node within the 
network in terms of how close it is to the centre of activity (Hanneman and 
Riddle, 2005). However, the definition of the “centre of activity” varies, and as 
such different centrality measures exist: 
o Degree centrality identifies which nodes are the most influential. This is 
measured by simply counting the number of other nodes directly 
connected to a given node (Abbasi et al., 2012). 
o Betweenness centrality measures the influence a node has over the 
spread of information across the network by calculating the number of 
times a particular node lies between the other nodes in the network 
(Abbasi et al., 2012). 
o Closeness centrality is a measure of how far information is spread from 
a given node to other reachable nodes in the network, and is calculated 
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as the sum of geodesic distances (the shortest path between any given 
node in a network) from a particular node to all the other nodes in a 
network (Abbasi et al., 2012). 
 
The extent of diagnostic device research activity between 2000 and 2016 was 
determined by considering the number of papers published per year.  
 
The dominant nodes in the network were identified by calculating the measures of 
degree, betweenness and closeness centrality. 
 
Inter-sectoral collaboration is a collaborative relationship between two different sectors 
at any time during the study period, while intra-sectoral collaboration represents a 
collaboration between nodes from the same sector (Chimhundu et al., 2015). Inter-
sectoral collaboration was calculated using the between group density metric, which 
measures the extent of interconnectedness between two different sectors, while intra-
sectoral collaboration was calculated using the within group density metric, which 
measures the extent of interconnectedness between two of the same sectors. Group 
density was then separately used to investigate local-only versus local-foreign 
collaboration. 
 
Given that five years is considered long enough to study the variations in publication 
rates (Newman, 2001; Baum et al., 2003; Eslami et al., 2013; Lander, 2013), five-year 
windows were used to asses changes in the collaboration patterns for diagnostic 
device development in South Africa over the study period.  
 
Disease-specific device types that have been developed in the South African context 
were investigated by generating disease-specific networks from the publication 
dataset. The same five-year window previously used was also applied to the most 
prominent disease category, to examine changes in device development activity for 
the dominant infectious disease. 
 
Finally, features of the diagnostic devices under development, as expressed in the 
publications, were examined to provide further insight into the types of devices being 
developed.  
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4. Results and Discussion 
 
This chapter presents the bibliometric data extracted, the collaboration networks 
drawn, and the analysis of the networks, using the methodology described in the 
previous chapter. 
 
4.1 Search Results 
 
Figure 4-1 shows the number of results yielded from the search of the databases, and 




















Figure 4-1: Number of studies yielded from the search of databases and the total number of 
studies retained for analysis 
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Figure 4-2 shows the number of publications plotted against time, thereby indicating 
the level of research activity per year over the 2000-2016 period. As no relevant 
publications were present in the data set before 2008, further analysis discusses 2008-
2016 as the study period.  
 
Figure 4-2: Number of publications per year addressing diagnostic device development for 
infectious diseases in South Africa during the period 2000-2016 
 
A total of 42 organisations (to be visualized as network nodes) were found within the 
retained dataset. Table 4-1 shows the number of local and foreign nodes in each 
sector. 
 
Table 4-1: Number of organisations (network nodes) between 2008 and 2016 forming the 
dataset of publications on South African diagnostic device development for infectious 
diseases. 
 Sector Total 






Local 4 2 0 3 10 
Foreign 16 8 4 5 32 
























4.2 Collaboration Network 
 
Figure 4-3 shows a collaboration network of local and foreign organisations that played 
an active role in medical device development for the diagnosis of infectious diseases 
during the period 2008-2016. Local and foreign nodes are differentiated by colour, 
sectors (U, H, I, S) are differentiated by node shape and the size of the nodes is scaled 
according to degree centrality. The edges were weighted according to the number of 




Figure 4-3: Collaboration network for diagnostic device development in South Africa during 
the period 2008-2016. Degree centrality was used to determine the size of the nodes. Edges 
were weighted according to the number of times collaboration occurred between two nodes. 
Abbreviations and full names of each node can be found in Appendix A. 
Foreign (pink) nodes feature more prominently in the network than local (light blue) 
nodoes, while universities (diamonds) are the most dominant sectors, both locally 
and internationally. Thus universities in foreign countries played an active role in the 
development of diagnostic devices in South Africa between 2008 and 2016. Based 
on the varying sizes of the nodes, the University of Cape Town (UCT), Stellenbosch 
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University (SUN) and the University of London (UL) are among the most active 
institutions in the diagnostic medical device development network.  
 
4.2.1 Dominant Nodes 
 
Table 4-2 shows a list of the 10 highest ranking nodes for each measure of centrality. 
A high degree centrality indicates that the node has high influence over other nodes; 
a high betweenness centrality indicates that a node has high influence over the spread 
of information across the network; and a high closeness centrality indicates that a 
node is able to spread information across the network most efficiently.  
 
Table 4-2: Top ten nodes ranked by highest to lowest measures of centrality (degree, 
closeness and betweenness). The full names of the organisations can be found in Appendix 
A.  
Rank 
Degree Centrality Closeness Centrality Betweenness Centrality 
Institution Sector Value Institution Sector Value Institution Sector Value 
1 UCT U 13 SUN U 9.404 SUN U 236.917 
2 UL U 11 UCT U 9.382 UCT U 210.250 




WITS U 9.297 UA U 175.000 
4 NHLS S RUMC H 9.213 UL U 114.750 
5 UA U UL U 
9.172 
NHLS S 71.667 




NHLS S WITS U 47.667 
7 UKZN U UCL S 9.131 RUMC H 17.500 
8 UiO U UA U 9.071 UiO U 
2.667 
 
9 WITS U RIVM S 
8.972 
UKZN U 
10 Seven organisations with equal degree* 7 SAMRC S OUH H 
 
U, University; H, Healthcare Services; I, Industry; S, Science councils and facilities 
*MSH (S), MU (U), PMNCH (S), RBC (S), UCDL (U), UN (U), UR (U). 
 
The findings in Table 4-2 indicate that UCT (University of Cape Town) has the highest 
ranked degree centrality in the network, meaning that it is the most influential node 
with regard to level of activity. It also has a high impact on the spread of information 
in the network and how efficiently this occurs, which is indicated by its high 
betweenness centrality and closeness centrality. While SUN (University of 
Stellenbosch) is the third most influential node in the network based on degree 
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centrality it has the highest impact on how information is spread (closeness centrality) 
and how efficiently this happens (betweenness centrality).  
 
Degree centrality on its own does not provide a complete indication of influence in the 
network, as it only identifies the node at the centre of activity in the network, and does 
not take into account the location within the network of the nodes connected to the 
node in question (Chimhundu et al., 2015). For example consider WITS (University of 
Witwatersrand) which has the 9th highest degree centrality value but the 3rd highest 
closeness centrality. Although WITS may not have a very high influence due to the 
limited number of nodes directly connected to it (i.e. relatively low degree centrality) it 
is connected to pivotal nodes within the network that enable it to spread information 
effectively (as indicated by the high closeness centrality). 
 
Chimhundu et al. (2015) presented an analysis of sectoral collaboration for 
cardiovascular medical device development over a period of 15 years by analysing 
two measures of centrality, namely degree and betweenness. In both the Chimhundu 
study and the present one, the U sector is in the most favourable position in the 
network, based on the degree centrality rankings (the majority of nodes ranked within 
the top 10 for degree centrality are from the U sector in both studies, and the top 
ranked nodes for degree centrality are from the U sector). Chimhundu et al. (2015) 
found that UCT, SUN and WITS were listed in the top five for both degree and 
betweenness centrality, while the present study showed that UCT and SUN are also 
present in the top 5 for both of these measures, however WITS is ranked 9th and 6th 
for degree and betweenness centrality respectively. 
 
The U sector is able to reach other actors at the shortest path lengths (closeness 
centrality; 5/10 organisations in Table 4-2). Finally, the 7/10 organisations within the 
top 10 for betweenness centrality were from the U sector indicating that they most 
frequently act as a link between any two nodes in the network and therefore have the 
highest capacity to act as a channel for knowledge propagation within the collaboration 




4.2.2 Inter- and intra-sectoral collaboration 
 
The density of a network gives an indication of the extent of overall collaboration within 
the network by measuring interconnectedness. It may also provide insight into how 
efficiently information is spread between groups within the network (Hanneman and 
Riddle, 2005). Table 4-3 shows the within-group densities (intra-sectoral collaboration) 
in bold and between-group densities (inter-sectoral collaboration) in normal text. 
 
Another value included in the table is the sum of edge weights (∑ew); this represents 
the total number of edges in the network that connect the nodes belonging to a 
particular grouping, taking into account the weight of the edges (Hanneman and 
Riddle, 2005). For example, the ∑ew that connects institutions from the U sector to 
those of the H sector is 32, and the ∑ew that connects the U and I sectors is 4. This 
means that institutions from the U and H sectors have collaborated 8 times more 
frequently than those in the U and I sectors during the same period based on the 
number of edges that connect them. 
 
Table 4-3: Extent of sectoral collaboration as measured using group density (𝞺𝞺) and sum of 
edge weights (∑ew). Within-group densities (intra-sectoral collaboration) are shown in bold 
and between-group densities (inter-sectoral collaboration) are in normal text. 
 U H I S 
 𝞺𝞺 ∑ew 𝞺𝞺 ∑ew 𝞺𝞺 ∑ew 𝞺𝞺 ∑ew 
U 0.210 88 0.169 32 0.048 4 0.185 31 
H 0.169 32 0.111 8 0.028 1 0 0 
I 0.048 4 0.028 1 0.167 2 0.031 1 
S 0.185 31 0 0 0.031 1 0.250 14 
U, University; H, Healthcare services; I. Industry; S. Science councils and facilities 
 
Intra-sectoral collaboration, which serves as an indication of the extent to which 
sectors collaborate amongst themselves, can be ranked from highest to lowest as S, 
U, I and H. Previous studies have shown that universities collaborate extensively with 
one another. Chimhundu et al. (2015) showed intra-sectoral collaboration was highest 
in the I sector and second highest in the H sector (with regard to cardiovascular 
devices), while in de Jager et al. (2017) collaboration within the university sector was 
the highest (with regard to medical devices in general. In the present study the U 
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sector has the second highest within group density (𝞺𝞺=0.210). Although the results 
show that in the context of diagnostic device development, the S sector has the 
strongest intra-sectoral collaboration (𝞺𝞺=0.250), the sum of edge weight values shows 
that the organisations within the U sector have worked on 88 instances of 
collaboration, while the organisations within the S sector have only worked on 14. 
Thus organisations within the S sector have worked on fewer published projects, but 
have preferred to collaborate within the S sector.  
 
With regard to inter-sectoral collaboration, the strongest combinations include SU (𝞺𝞺 
= 0.185; ∑ew = 31) and HU (𝞺𝞺 = 0.169; ∑ew = 32), and the weakest are HI (𝞺𝞺 = 0.028; 
∑ew = 1) and SI (𝞺𝞺 = 0.031; ∑ew = 1). In the same way as shown in Chimhundu et al. 
(2015), the top two collaboration densities (SU = 0.185; HU = 0.169) indicate that the 
U sector acts as a liaison between the sectors.  
 
Table 4-4 shows the extent of collaboration based on the location of the nodes (local 
only collaboration and local-foreign collaboration). The density for local-local (l-l) 
collaboration (0.356) is higher than for local-foreign (l-f) (0.150), which corresponds 
with de Jager et al.’s (2017) findings, and indicates that local organisations collaborate 
more with foreign organisations than with each other.  When taking into account the 
local nodes and edges in the cardiovascular medical device network, compared to the 
local and foreign nodes and edges combined, Chimhundu et al. (2015) observed that 
foreign nodes serve to connect nodes that would otherwise not have been connected 
by providing alternate pathways for knowledge transfer. As seen in the current 
network, the local nodes form connections irrespective of the foreign nodes. 
 
Table 4-4: Extent of local and foreign collaboration as measured using group density (𝞺𝞺) and 
sum of edge weights (∑ew). Within-group densities (local-local collaboration) are shown in 
bold and between-group densities (local-foreign collaboration) are in normal text. 
 Local 
 𝞺𝞺 ∑ew 
Foreign 0.150 48 
Local 0.356 32 
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4.2.3 Network Development over Time 
  
In order to assess the change in activity for diagnostic device development over the 
period of study, two five-year windows, one at the beginning of the study period  
(2008-2012; Figure 4-4) and one at the end (2012-2016; Figure 4-5) were 
investigated. The degree centrality values were calculated for both networks and  
normalised to allow for comparison across the two networks (Freeman, 1978). The 
results are shown in Table 4-5 and Table 4-6 respectively.  
 
For the 2008-2012 period, Figure 4-4 shows a similar presence of foreign and local 
nodes (8 foreign; 6 local), and at least three organisations contributing from each 
sector. The university sector is at the centre of device development activity, with 
UCT and SUN having the highest and third highest degree centrality measures at 
0.615 and 0.385 respectively, as shown in Table 4-6. 
 
UCT continues to hold a central position during the 2012-2016 period (Figure 4-5), 
with a degree centrality of 0.229 (Table 4-6), however two other local institutions 
have become prominent in this network, namely UKZN (degree centrality = 0.229) 
and WITS (degree centrality = 0.229). Also evident in Figure 4-5 is the dominant 
presence of foreign institutions (27 foreign nodes, 9 local nodes), most of which are 
universities (21 universities out of 36 total institutions). Narin et al. (1991) found that 
scientifically small countries tend to collaborate more with scientists outside of the 
country as there are more external scientists to with whom collaborate. Similarly, 
Boshoff (2009) noted that researchers in developed countries seek to collaborate 
with researchers in developing countries in order to access data. In the case 
infectious diseases, South Africa presents opportunities to foreign researchers to 





Figure 4-4: Collaboration network for diagnostic medical device development in South Africa 
during the period 2008-2012. Degree centrality was used to determine the size of the nodes. 
Edges were weighted according to the number of times collaboration occurred between two 
nodes. 
 
Table 4-5: Top 10 organisations for degree centrality for 2008-2012. The values for institutions 
that had an identical degree centrality were merged. The full names of the organisations can 
be found in Appendix A.  
Rank 
Degree Centrality 
Institution Sector Value 
1 UCT U 0.615 
2 NHLS S 
0.385 
3 SUN U 





5 UL U 
6 UMC-U H 
7 SAMRC S 
8 RIVM S 
9 UCL U 
0.154 






Figure 4-5: Collaboration network for diagnostic device development in South Africa during 
the period 2012-2016. Degree centrality was used to determine the size of the nodes. Edges 
were weighted according to the number of times collaboration occurred between two nodes. 
 
Table 4-6: Top 10 organisations for degree centrality for 2012-2016. The values for institutions 
that had an identical degree centrality were merged. The full names of the organisations can 
be found in Appendix A.  
Rank 
Degree Centrality 
Institution Sector Value 
1 UA U 0.257 
2 UCT U 
0.229 
 
3 OUH H 
4 UKZN U 
5 UiO U 
6 UL U 
7 WITS U 
8 
7 institutions with equal 
degree* 0.200 9 
10 






4.3 Disease-Specific Network 
 
Four diseases appeared in the dataset (Table 4-8) and a collaboration network was 
constructed to show the collaborative diagnostic device research activity for each 
disease. Networks are shown in Figure 4-5 through 4-8; each disease (tuberculosis, 
HIV/AIDS, malaria and female genital schistosomiasis – FGS) is represented by 
different a colour and the size of each node represents how many publications the 
particular node has published on a specific disease. The edges were weighted 
according to the number of times two nodes have collaborated.  The node sizes across 
Figures 4-5 – 4.10 are drawn to the same scale, with a particular node size 
representing the same number of publications. The institutions that have not published 
any papers on the given disease are coloured in black. 
 
Table 4-7: Diseases addressed by diagnostic medical device research in South Africa 










Tuberculosis 57 5 20 
HIV 1 3 5 
Malaria 1 2 0 
Female genital 
schistosomiasis 
2 2 7 
 
Figure 4-6 shows that while the majority of the nodes in the network are involved in 
TB diagnostic research, UCT, SUN and RUMC (Radboud University Medical Center) 
have contributed the most papers in the field (15, 7, and 4 respectively). On a sectoral 
level, research on device development for TB is dominated by the universities and 
hospitals based on the number of papers produced by each (U-19; H-8)). Very few 
actors (8) are involved in HIV device development and even fewer (2) in malaria device 
development, as shown in Figure 4-7 and Figure 4-8 respectively, and in addition, 
these networks only reflect one publication each.  
 
Research aimed at FGS device development is dominated by foreign organisations, 
which make up 7 out of the 9 organisations that have contributed to publications 
 35 
addressing the disease. (Figure 4-9). The FGS cluster also appears as an isolated 
cluster of activity separate from the larger network. FGS is a waterborne parasitic 
disease that is primarily found in the poor regions of Sub-saharan Africa (Mbabazi et 
al., 2011) and primarily affects young women (Downs et al., 2011). Although South 
Africa does not fall under the top 5 countries in sub-Saharan Africa with the highest 
burden of FGS (Adenowo et al., 2015), it has been hypothesised that it increases the 
susceptibility of HIV in women (Magaisa et al., 2015), which is an important public 
health concern in the South African context. Studies have shown that women with 
FGS had a higher chance of contracting HIV than women who did not (Mbabazi et al., 
2011). The two local universities in the FGS network, Durban University of Technology 
(DUT) and the University of Kwazulu-Natal (UKZN) are located in Kwazulu-Natal, 
which had the highest provincial prevalence of HIV in South Africa in 2015 (National 
Department of Health, 2015). This is also a province of South Africa that is endemic 




Figure 4-6: Network representation of diagnostic medical device research addressing 
tuberculosis (TB) in South Africa between 2008-2016. The size of the nodes was determined 
by the number of publications by each organisation. Edges were weighted according to the 





Figure 4-7: Network representation of diagnostic medical device research addressing 
HIV/AIDS in South Africa between 2008-2016. The size of the nodes was determined by the 
number of publications by each organisation. Edges were weighted according to the number 























Figure 4-8: Network representation of diagnostic medical device research addressing 
malaria in South Africa between 2008-2016. The size of the nodes was determined by the 
number of publications by each organisation. Edges were weighted according to the number 











Figure 4-9: Network representation of diagnostic medical device research addressing female 
genital schistosomiasis (FGS) in South Africa between 2000-2016. The size of the nodes 
was determined by the number of publications by each organisation. Edges were weighted 
according to the number of times collaboration occurred between two nodes. 
 
With TB being the disease that is most frequently addressed by diagnostic device 
development research, two additional networks were constructed to show the 
change over time of the TB network (Figure 4-10 and Figure 4-11). As in Figure 4-4 
and Figure 4-5, the time periods considered were 2008-2012 and 2012-2016. The 
results show that UCT and SUN played a dominant role in publishing papers 
addressing diagnostic medical devices for TB, as shown by the sizes of the nodes, 
which represent the number of publications the institutions have published. TB 
diagnostic device research activity was higher during 2012-2016, despite its lower 
rank in Table 1-1, which shows that TB was the 6th out of 10 leading causes of 
disease in South Africa in 2016. The results presented in Figure 4-11 show that 
foreign organisations (SMMS, RIVM, UCL, GTI, GEH, UL, UMC-U, RUMC) were the 





Figure 4-10: Network representation of diagnostic medical device research addressing TB in 
South Africa between 2008-2012. The size of the nodes was determined by the number of 
publications by each organisation. Edges were weighted according to the number of times 







Figure 4-11: Network representation of diagnostic medical device research addressing TB in 
South Africa between 2012-2016. The size of the nodes was determined by the number of 
publications by each organisation. Edges were weighted according to the number of times 
collaboration occurred between two nodes. 
 
4.4 Focus Areas 
 
Table 4-8 shows the specific focus areas of diagnostic device development in South 
Africa with regard to infectious diseases. A list of diagnostic device features is 
presented along with the diseases that each one is intended to diagnose. The 
locations (local/foreign) of the co-authors involved in the development of each device 
as well as the funders of the research, have also been included in the table.   
 
Of all the medical device features that appeared in the dataset, which consisted of the 
28 publications listed in Table 4-8, computer-aided diagnosis was the most frequently 
addressed by diagnostic medical device research (12/28 publications). In terms of the 
motivation for each device type, the following observations were made from the 
relevant papers: 
• Publication number 6 (Jager et al., 2014) stated that the purpose of their 
computer-aided diagnosis was to increase efficiency and improve detection 
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accuracy, by reducing reliance on qualified technicians which are in short 
supply.  
• Publication number 7 (Soobratty et al., 2014) presents a device uses 
nanomaterial-based sensors, which are sensitive and inexpenisive, to detect 
TB at the point of care through the analysis of exhaled alveolar breath. 
• Publication 23 (Dang et al., 2015) and 27 (Mourão et al., 2016) present an  
adaptation to the GC/MS, which uses liquid extraction and solid phase 
extraction procedures to detect TB. Besides its high sensitivity, the authors 
claim that the device is also user-friendly and inexpensive, which is a useful 
characteristic in poor, resource-limited settings (Dang et al., 2015).  
 
Although the table shows that the device development which has occurred between 
2008 and 2016 has addressed some of the South African disease burden, there is a 
lack of point-of-care (POC) device activity. POC devices are known to be automated 
and portable and to provide a rapid result (Price, 2001; Choi, 2016) which helps to 
address the shortage of resources and skilled technicians in low-income settings. As 
such, at the outset of this study, it was expected to see POC devices in the diagnostic 
device development landscape. However, the study outcome showed that the focus 
has instead been on software for devices such as microscopes and X-ray machines, 
which are based in laboratories or health facilities (see Table 4-8). Two devices in the 
table qualify as POC diagnostic devices; publication number 19 (Robbins et al., 2014) 
presents a smartphone application for HIV diagnosis. Given that the application is able 
to run on any android device, it allows for screenings to be administered in any location 
(rural or urban) by any healthcare profession (Robbins et al., 2011). A limitation of this 
device would be that it can only be used on smartphones or tablets, which may not 
always be accessible in resource-limited areas. Publication number 7 is based on the 
use of organic nano-material sensors that are able to detect active TB through a breath 
test, and the authors claim it is also noninvasive and inexpensive (Soobratty et al., 
2014). 
 
Also shown in Table 4-8 is the source of funding for the research of each diagnostic 
medical device. While all the publications with a foreign author have at least one 
foreign funder, some of the local development activity also has foreign funders, which 
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indicates that the funding source does not appear to determine whether or not foreign 











Table 4-8: Features of diagnostic medical devices research and diseases addressed as discussed in the 28 South African affiliated journal articles 
between 2008 and 2016 
 
 Author Diseases addressed Device Type 
Location of co-
authors Source of Funding 
1. (Hogeweg et al., 2010) Tuberculosis Computer-aided detection – chest X-rays Foreign/Local  
2. (Khutlang et al., 2010) Tuberculosis Computer-aided detection – sputum smear microscopy Local  
3. (Irving et al., 2011)  Tuberculosis Computer-aided detection – chest X-rays Foreign/Local Commonwealth Scholarship Commission 
4. (Dendere et al., 2011) Tuberculosis Image processing – automated microscopy Local  
5. (Divekar et al., 2012) Tuberculosis Computer-aided detection – sputum smear microscopy Foreign/Local  
6. (de Jager et al., 2014) Tuberculosis Image processing – automated microscopy Local  
7. (Soobratty et al., 2014) Tuberculosis Nanomaterial-based sensors Foreign/Local Sir Halley Stewart Trust 
8. (Hogeweg et al., 2015) Tuberculosis Computer-aided detection – chest X-rays Foreign/Local  
9. (Marais et al., 2008) Tuberculosis LED light source – fluorescence microscopy Local  
10. (Halberstadt and Douglas, 2008) 
Tuberculosis Computer-aided detection – CT images Local National Research Foundation, Abdus Salam 
International Centre for Theoretical Physics, 
Swedish International Development Cooperation 
Agency 
 
11. (Frean, 2009) Malaria Image processing –automated microscopy Local University of Witwatersrand, National Health Laboratory Services 
12. (Mouton et al., 2010) Tuberculosis Computer-aided detection – chest X-rays Local  
13. (Khutlang et al., 2010) Tuberculosis Computer-aided detection – sputum smear microscopy Local  
14. (Osibote et al., 2010) Tuberculosis Image processing – automated microscopy Local National Institutes of Health 
 44 
15. (Patel and Douglas, 2011) Tuberculosis Image processing –automated microscopy Local National Institutes of Health 
16. (Van Wyk et al., 2011) Tuberculosis LED light source –fluorescence microscopy Local SATBAT, National Institutes of Health, Fogarty International Center 
17. (Tezoo and Douglas, 2012) Tuberculosis Computer-aided detection – chest rays Local 
Lodox Systems, Technology and Human 
Resources for Industry Programme 
18. (Patel and Douglas, 2012) Tuberculosis Image processing – automated microscopy Local National Institutes of Health 
19. (Robbins et al., 2014) 
HIV Smartphone Application Foreign/Local National Institute of Mental Health to the HIV 
Center for Clinical and Behavioral Studies, 
Manhattan HIV Brain Bank at the Mount Sinai 
School of Medicine 
 
 
20. (Irving et al., 2014) Tuberculosis Computer-aided detection – CT images Foreign/Local Commonwealth Scholarship Commission 
21. (Ismail et al., 2015) Tuberculosis Image processing – automated microscopy Local  
22. (Holmen et al., 2015) Female Genital Schistosomiasis Image processing –automated microscopy Foreign/Local  
23. (Dang et al., 2015) Tuberculosis Adapted GC/MS based on liquid extraction and solid-phase clean-up Foreign/Local 
UBS Optimus Foundation, NanoNext NL 
 
24. (Holmen et al., 2015) Female Genital Schistosomiasis Image processing – automated microscopy Foreign/Local  
25. (Philipsen et al., 2015) Tuberculosis Computer-aided detection – chest X-ray Foreign/Local European and Developing Countries Clinical Trials Partnership  
26. (Melendez et al., 2016) Tuberculosis Computer-aided detection – chest X-ray Foreign/Local European and Developing Countries Clinical Trials Partnership  
27. (Mourão et al., 2016) Tuberculosis Adapted GC/MS based on liquid extraction and solid-phase clean-up Foreign/Local UBS Optimus Foundation, NanoNext NL 
28. (Ngabonziza et al., 2016) Tuberculosis LED light source– sputum smear microscopy Foreign/Local 
East African Public Health Laboratory 
Networking 
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4.5 Summary  
 
The first diagnostic medical device publications within the 2000-2016 period 
appeared in 2008. Two independent collaboration networks were identified, one of 
which exhibited the collaborative research activity for the development of diagnostic 
tools for HIV/AIDS, TB and malaria, and the other which exhibited the research 
activity for FGS. The degree centrality results showed that UCT is the most 
influential institution, while the closeness and betweenness centrality results showed 
that SUN has a substantial impact on how information is transferred throughout the 
network. On a sectoral level, the local university sector was found to be an important 
link between other sectors and nodes, in that it formed the most inter-sectoral 
collaboration with the hospital and science council sectors. There was a high 
presence of foreign nodes in the network (32/42 nodes). TB was found to be the 
most frequently addressed disease in diagnostic device development in South Africa 
(57 publications), with UCT (15 publications) and SUN (7 publications) contributing 
the most research in this field. The development of automated detection methods, 
which was discussed in 12 out of the 28 articles, was the prominent focus of TB-
related diagnostic device development activity during the 9-year period from 2008 to 
2016.  
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5. Conclusion and Recommendations 
 
The study investigated the landscape of diagnostic medical device development in 
South Africa by constructing a collaboration network and identifying influential 
institutions, collaboration trends and paths for knowledge propagation in the network. 
Future research could examine patenting activity for a richer analysis of diagnostic 
device activity. An analysis of the type of collaboration activity that successfully 
produced products that have reached the market or the clinic would also be useful. 
Insights into the barriers to and the drivers of successful diagnostic device innovation 
would be gained through detailed case studies of collaborations identified in the 
networks. Such knowledge would be beneficial to future technological and policy 
developments aimed at improving access to diagnostic services and treatment in the 
South African context. 
 
While point-of-care tests are well suited to developing countries such as  South Africa, 
the diagnostic device features listed in Table 4-10 indicate that little research has been 
directed at POCTs. According to a global market forecast published by Markets and 
Markets (2014), the global POC diagnostics market in developing countries has grown 
at a lower compound annual growth rate (CAGR) than in developed countries since 
2013. However, the global market is expected to experience high growth in the future, 
particularly in emerging countries such as Brazil, Russia, India, China and South 
Africa. This is due to factors such as the increased prevalence of lifestyle diseases, 
persisting infectious diseases, increased usage of home-based POC devices and 
decreasing numbers of technicians in central labs (Markets and Markets, 2014). If 
reliance on internationally developed devices is to be avoided, countries like South 
Africa should consider investing in POC development research. 
 
A limitation of this study is that only journal and conference articles were included. 
Given that the publishing of journal articles is considered as an academic exercise, 
the activity present in other sectors, particularly the industry sector, tends to be under-
represented. It would therefore be useful to conduct a separate study to establish 
collaboration trends within the industry sector based on the analysis of patents as a 
way to account for this limitation. Another limitation is that although bibliometric studies 
typically use co-authorship as a proxy for collaboration, Laudel (2002) stated that 
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collaborators are only awarded co-authorship status based on the type of contribution 
they have made to the publication (Laudel, 2002), and certain types of collaboration 
may not be reflected in co-authorship. Finally, the affiliation of multiple authors with 
one organization was not considered in the analysis and therefore collaboration within 
institutions has not been considered (Chimhundu, et al., 2015).  
 
Further research is required to understand the motivations that underlie collaborations 
in medical device development, and to explore the unique contributions of different 
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Full Name Abbreviation Local/Foreign 
Universities 
Columbia University CU Foreign 
Durban University of Technology DUT Local 
Johns Hopkins University JHU Foreign 
Makerere University MU  Foreign 
The Mannheim University of Applied Sciences UMA Foreign 
Universite Catholique de Louvain UCDL Foreign 
University College London UCL Foreign 
University of Agder UiA Foreign 
University of Amsterdam UA Foreign 
University of Bergen UiB Foreign 
University of Birmingham UBir Foreign 
University of Cape Town UCT Local 
University of Copenhagen UCPH Foreign 
University of Kwazulu-Natal UKZN Local 
University of London UL Foreign 
University of Nairobi UN Foreign 
University of Oslo UiO Foreign 
University of Pretoria UP Local 
University of Rwanda UR Foreign 
University of Stellenbosch SUN Local 
University of Witwatersrand WITS Local 
Healthcare Services 
Guy’s and St. Thomas Hospital GSTH Foreign 
Leiden University Medical Centre LUMC Foreign 
Mount Sinai Medical Centre MSMC Foreign 
Oslo University Hospital OUH Foreign 
Radboud University Medical Centre RUMC Foreign 
Sorlandet Hospital SH Foreign 
Tygerberg Hospital TH Local 
University Medical Centre Utrecht UMC-U Foreign 
Industry 
Envisage IT EI Foreign 
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General Electric Healthcare GEH Foreign 
Guardian Technologies International Inc. GTI Foreign 
Signature Mapping Medical Sciences Inc. SMMS Foreign 
Science Councils and Facilities 
Institute of Tropical Medicine Prince Leopold PMNCH Foreign 
Management Sciences for Health MSH Local 
National Health Laboratory Services NHLS Local 
Rwanda Biomedical Centre RBC Foreign 
South African Medical Research Council SAMRC Local 
The Aurum Institute TAI Local 
The National Institute for Public Health and Environment RIVM Foreign 
Unilever Research and Development Vlaardingen URDV Foreign 
